JILL RICHMOND: Open Payments
NPI 1922674662 · LOUISA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$475 in 25 payments from 9 companies in 2025. Trend: 2023 $173 · 2024 $631 · 2025 $475
Food & beverage: $475
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $119 |
| AstraZeneca Pharmaceuticals LP | 6 | $95 |
| Novo Nordisk Inc | 4 | $69 |
| ABBVIE INC. | 3 | $68 |
| Lilly USA, LLC | 3 | $48 |
| PFIZER INC. | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Viatris Specialty LLC | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: VRAYLAR, REPATHA, OTEZLA, Ozempic, BREZTRI, MOUNJARO, AIRSUPRA, ELIQUIS.
Industry payments across VA — which companies pay providers there.
